BIOMATRICA, INC.
Ambient-temperature stable formulations for HIV-1 genotyping reagents enabling room-temperature shipping and long-term storage
- Sector
- Biotech
- Headquarters
- SAN DIEGO, CA
- Latest Form D
- $18.1M, Dec 2017
- Total capital
- $24.3M
- Federal grants
- $140K
- 1 award · 2015
- Rank in peer group#6 of 54
- Private capital raised
- $21.2M
- 4 Form D · last Dec 2017
- 106 months since last filing
- Federal contracts
- $3M
- 12 awards · Health and Human S, Defense, Justice
- Rank in Biotech#108 of 4373
- Granted patents
- 10
- 30 pending · first 2017
- Rank in peer group#8 of 54
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 4th filing$18.1M
- Federal contractDefense · Igf::ot::igf - Bto Studies; Ffp Milestone Contract For "stabilization Of Mosquito Eggs For Long Term Storage And Use In Vector Control Programs"$93K
- Federal contractJustice · Dnastable Plus Ld 10ML (cat# 52091026)$29K
- Federal grantHealth and Human S · Phase I · PA14-071 SBIR: Development and application of a liquid reagent drying system for CDC HIV-1 PanGroup M genotyping Assay reagents$140K
- Federal contractDefense · Collection Tubes$6K
- Federal contractHealth and Human S · Igf::cl::igf$150K
- Federal contractDefense · Blood Tube Kit$4K
- Private capital raisedForm D · SEC · 3rd filing$3M
- Offering registeredForm D · SEC · 2nd filing$298K
- Offering registeredForm D · SEC · 1st filing$5M
Show 7 earlier federal awards
- Federal contractDefense · Biomolecule And Cell Preservation Technology For Point Of Care Diagnostic And Forensic Applications$1.4M
- Federal contractDefense · SBIR Phase I Army 2011.2, Erms #11255004, Proposal #A112-107-0888$1.1M
- Federal contractHealth and Human S · Chemicals$4K
- Federal contractHealth and Human S · Chemicals$4K
- Federal contractHealth and Human S · TAS::75 0849::TAS Alternative Biospecimen Stabilization And Storage Solutions$146K
- Federal contractHealth and Human S · TAS::75 4554::TAS NIH Service And Supply Fund$4K
- Federal contractHealth and Human S · Laboratory Equipment And Supplies$4K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
10months
from BIOMATRICA, INC.’s first federal award to its first private round.
- First federal award · Mar 2010
- Health and Human S · $4K
- First Form D · Dec 2010
- $5M · 1st Form D
- Awards before first raise
- 4 awards
An association in public records, not a cause or a prediction.
Standing among 54 peers
Line = medianBiotech · Material
- Federal grants#6 · top 11%
- Granted patents#8 · top 15%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Rolf MullerResearcherExecutive Officer, DirectorLinked by 4 patents
- Francois FerreDirectorNamed in SEC Form D filings
- Joe MarkeeDirectorNamed in SEC Form D filings
- John ThompsonDirectorNamed in SEC Form D filings
- Joseph MarkeeExecutive Officer, DirectorNamed in SEC Form D filings
- Judy Muller-CohnExecutive Officer, DirectorNamed in SEC Form D filings
Show all 9 people
- Nick EcosExecutive Officer, DirectorNamed in SEC Form D filings
- Tolf MullerExecutive Officer, DirectorNamed in SEC Form D filings
- Tony BroadExecutive OfficerNamed in SEC Form D filings
What it has protected
USPTO · 10 granted of 40- PendingStabilization Of Thrombocytes At Ambient TemperaturesUSPTOApplication 18890348
- GrantedStabilization Of Thrombocytes At Ambient TemperaturesUSPTOUS 12,121,022
- GrantedReduction Of Erythrocyte Sedimentation RateUSPTOUS 12,089,588
Show all 40 patent records
- Stabilization Of Thrombocytes At Ambient TemperaturesMay 22, 2025 · Application 18890348Pending
- Stabilization Of Thrombocytes At Ambient TemperaturesOct 22, 2024 · US 12,121,022Granted
- Reduction Of Erythrocyte Sedimentation RateSep 17, 2024 · US 12,089,588Granted
- Stabilization Of Thrombocytes At Ambient TemperaturesJun 13, 2023 · US 11,672,247Granted
- Reduction Of Erythrocyte Sedimentation RateSep 14, 2021 · US 11,116,205Granted
- Stabilization Of Nucleic Acids On PaperAug 3, 2021 · US 11,078,521Granted
- Stabilization Of Non-denatured Polypeptides, Nucleic Acids, And Exosomes In A Blood Sample At Ambient TemperaturesFeb 4, 2021 · Application 17073580Pending
- Stabilization Of Metabolically-active Cells In A Blood Sample At Ambient TemperaturesJan 7, 2021 · Application 17028068Pending
- Stabilization Of Thrombocytes At Ambient TemperaturesSep 15, 2020 · US 10,772,319Granted
- Reduction Of Erythrocyte Sedimentation RateFeb 25, 2020 · US 10,568,317Granted
- Stabilization Of Pcr Reagents And AssaysDec 20, 2018 · Application 15780580Pending
- Stabilization Of Thrombocytes At Ambient TemperaturesSep 4, 2018 · US 10,064,404Granted
- Compositions For Stabilizing Dna, Rna And Proteins In Blood And Other Biological Samples During Shipping And Storage At Ambient TemperaturesJun 19, 2018 · US 9,999,217Granted
- Formulations And Methods For Stabilizing Pcr ReagentsAug 8, 2017 · US 9,725,703Granted
- Stabilization of Metabolically-Active Cells in a Blood Sample at Ambient TemperaturesJul 20, 2017 · Application 15316686Pending
- Stabilization of Non-Denatured Polypeptides, Nucleic Acids, and Exosomes in a Blood Sample at Ambient TemperaturesJul 13, 2017 · Application 15316680Pending
- Cell StabilizationApplication 61834517Pending
- Compositions For Stabilizing Dna, Rna And Proteins In Blood And Other Biological Samples During Shipping And Storage At Ambient TemperaturesApplication PCTUS2011045404Pending
- Compositions For Stabilizing Dna, Rna And Proteins In Saliva And Other Biological Samples During Shipping And Storage At Ambient TemperaturesApplication PCTUS2011045405Pending
- Compositions And Methods For Biological Sample StorageApplication PCTUS2010034454Pending
- Integration Of Sample Storage And Sample Management For Life ScienceApplication PCTUS2008068628Pending
- Sample Storage For Life ScienceApplication PCTUS2008061332Pending
- Integration Of Sample Storage And Sample Management For Life ScienceApplication PCTUS2006045661Pending
- Reduction Of Erythrocyte Sedimentation RateApplication 62264786Pending
- Integration Of Sample Storage And Sample Management For Life ScienceApplication PCTUS2005012084Pending
- Stabilization Of Proteins In Biological SamplesApplication PCTUS2019031450Pending
- Stabilization Of Proteins In Biological SamplesApplication 62668955Pending
- Stabilization Of Nucleic Acids On PaperApplication PCTUS2017058136Pending
- Stabilization Of Pcr Reagents And AssaysApplication PCTUS2016065200Pending
- Reduction Of Erythrocyte Sedimentation RateApplication PCTUS2016065198Pending
- Stabilization Of Nucleic Acids On PaperApplication 62411996Pending
- Stabilization Of Pcr Reagents And AssaysApplication 62264758Pending
- Stabilization Of Non-denatured Polypeptides, Nucleic Acids, And Exosomes In A Blood Sample At Ambient TemperaturesApplication PCTUS2015034968Pending
- Stabilization Of Metabolically-active Cells In A Blood Sample At Ambient TemperaturesApplication PCTUS2015034969Pending
- Stabilization Of Thrombocytes At Ambient TemperaturesApplication PCTUS2015034967Pending
- Cell StabilizationApplication PCTUS2014042396Pending
- Stabilization Of Metabolically-active Cells In A Blood Sample At Ambient TemperaturesApplication 62010237Pending
- Stabilization Of Non-denatured Polypeptides And Nucleic Acids In A Blood Sample At Ambient TemperaturesApplication 62010164Pending
- Stabilization Of Inactivated Thrombocytes In A Blood Sample At Ambient TemperaturesApplication 62010151Pending
- Formulations And Methods For Stabilizing Pcr ReagentsApplication PCTUS2013077290Pending
Related companies, and why
- SynthegoSimilar federal contract value in Biotech · $3.2M in contracts
- NEOVAXSYN INCSimilar federal contract value in Biotech · $3.2M in contracts
- BOLDER BIOTECHNOLOGY INCSimilar federal contract value in Biotech · $3.1M in contracts
- APOGEE BIOTECHNOLOGY CORPORATIONSimilar federal contract value in Biotech · $3M in contracts
- AKINA, INC.Similar federal contract value in Biotech · $3M in contracts
- ACTIVE MOTIF, INC.Similar federal contract value in Biotech · $2.9M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .